首页> 外文期刊>Current Opinion in Biotechnology >Cancer stem cells in solid tumors
【24h】

Cancer stem cells in solid tumors

机译:实体瘤中的癌症干细胞

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer stem cells (CSCs) are cells that drive tumorigenesis, as well as giving rise to a large population of differentiated progeny that make up the bulk of the tumor, but that lack tumorigenic potential. CSCs have been identified in a variety of human tumors, as assayed by their ability to initiate tumor growth in immunocompromised mice. Further characterization studies have demonstrated that gene expression profiles in breast cancer correlate with patient prognosis, and brain CSCs are specifically resistant to radiation through DNA damage repair. In addition, specific signaling pathways play a functional role in CSC self renewal and/or differentiation, and early studies indicate that CSCs are associated with a microenvironmental niche. Thus the biological properties of CSCs are just beginning to be revealed, and the continuation of these studies should lead to the development of CSC-targeted therapies for cancer treatment.
机译:癌症干细胞(CSC)是驱动肿瘤发生的细胞,并且会引起大量分化后代,这些分化后代构成了肿瘤的大部分,但缺乏致癌潜力。通过在免疫功能低下的小鼠中启动肿瘤生长的能力进行分析,已在多种人类肿瘤中鉴定出了CSC。进一步的表征研究表明,乳腺癌中的基因表达谱与患者的预后相关,并且脑CSC对通过DNA损伤修复产生的辐射具有特殊的抵抗力。此外,特定的信号通路在CSC自我更新和/或分化中起功能性作用,早期研究表明CSC与微环境环境有关。因此,CSC的生物学特性才刚刚开始被揭示,并且这些研究的继续应导致针对癌症的CSC靶向疗法的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号